Nova Eye Medical Overview
- Year Founded
-
1970
- Status
-
Public
- Employees
-
301
- Stock Symbol
-
EYE
- Investments
-
3
- Share Price
-
$0.11
- (As of Thursday Closing)
Nova Eye Medical General Information
Description
Nova Eye Medical Ltd designs, develops, manufactures, markets and sells glaucoma surgical devices (GSD) for the market. Its devices are used by ophthalmic surgeons to reduce intraocular pressure (IOP) in patients with glaucoma. The company earns all its revenues from the sales of surgical devices for the treatment of glaucoma. Its AlphaRET segment is responsible for the commercialization of the 2RT ophthalmic laser; a potential treatment to delay progression to late-stage AMD for patients who have the disease in its intermediate stage. Its segments include Glaucoma Surgical Devices segment includes the design, manufacture, marketing and sale of the iTrack, iTrack Advance and the Molteno3 glaucoma surgical device; and AlphaRET.
Contact Information
Website
www.nova-eye.comCorporate Office
- 107 Rundle Street
- Kent Town, South Australia 5067
- Australia
Corporate Office
- 107 Rundle Street
- Kent Town, South Australia 5067
- Australia
Nova Eye Medical Stock Performance
As of 19-Nov-2026, Nova Eye Medical’s stock price is $0.11. Its current market cap is $30.6M with 285M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.11 | $0.11 | $0.07 - $0.14 | $30.6M | 285M | 200K |
Nova Eye Medical Financials Summary
As of 30-Sep-2026, Nova Eye Medical has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2026 30-Jun-2026 | FY 2025 30-Jun-2025 | FY 2024 30-Jun-2024 |
|---|---|---|---|---|
| EV | 27,880 | 20,702 | 21,187 | 32,549 |
| Revenue | 23,619 | 18,936 | 15,286 | |
| EBITDA | (1,380) | (4,351) | (3,837) | |
| Net Income | (2,935) | (5,861) | (5,760) | |
| Total Assets | 14,857 | 17,312 | 19,973 | |
| Total Debt | 1,648 | 1,971 | 2,238 |
Nova Eye Medical Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Nova Eye Medical Comparisons
Industry
Financing
Details
Nova Eye Medical Competitors (8)
One of Nova Eye Medical’s 8 competitors is Wontech Co., a Formerly VC-backed company based in Daejeon, South Korea.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Wontech Co. | Formerly VC-backed | Daejeon, South Korea | ||||
| Atricure | Formerly VC-backed | Mason, OH | ||||
| IRIDEX | Formerly VC-backed | Mountain View, CA | ||||
| DUKE Empirical | Private Equity-Backed | Morgan Hill, CA | ||||
| Staar Surgical | Corporation | Lake Forest, CA |
Nova Eye Medical Patents
Nova Eye Medical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2025524963-A | Apparatus and method for determining the location of an object of interest in a patient's eye, and ophthalmic apparatus | Pending | 25-Jul-2022 | ||
| AU-2023315289-A1 | Device and method for determining location of an object of interest within an eye of a patient, and ophthalmic apparatus | Pending | 25-Jul-2022 | ||
| EP-4311475-A1 | Device and method for determining location of an object of interest within an eye of a patient, and ophthalmic apparatus | Pending | 25-Jul-2022 | ||
| US-20250169692-A1 | Device and method for determining location of an object of interest within an eye of a patient, and ophthalmic apparatus | Pending | 25-Jul-2022 | ||
| US-20260033719-A1 | Device and method for determining location of an object of interest within an eye of a patient, and ophthalmic apparatus | Inactive | 25-Jul-2022 | A61B3/13 |
Nova Eye Medical Signals
Nova Eye Medical Investments & Acquisitions (3)
Nova Eye Medical’s most recent deal was a Corporate Asset Purchase with Innovative Glaucoma Solutions (Glaucoma Patents) for . The deal was made on 26-Aug-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Innovative Glaucoma Solutions (Glaucoma Patents) | 26-Aug-2021 | Corporate Asset Purchase | Buildings and Property | ||
| Molteno (Molteno3 Glaucoma Drainage Device Platform) | 02-Aug-2020 | Corporate Asset Purchase | Buildings and Property | ||
| iScience Interventional | 31-Dec-2013 | Merger/Acquisition | Other Pharmaceuticals and Biotechnology |
Nova Eye Medical ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Healthcare
Industry
Rank
Percentile
Medical Devices
Subindustry
Rank
Percentile
Nova Eye Medical FAQs
-
When was Nova Eye Medical founded?
Nova Eye Medical was founded in 1970.
-
Where is Nova Eye Medical headquartered?
Nova Eye Medical is headquartered in Kent Town, Australia.
-
What is the size of Nova Eye Medical?
Nova Eye Medical has 301 total employees.
-
What industry is Nova Eye Medical in?
Nova Eye Medical’s primary industry is Surgical Devices.
-
Is Nova Eye Medical a private or public company?
Nova Eye Medical is a Public company.
-
What is Nova Eye Medical’s stock symbol?
The ticker symbol for Nova Eye Medical is EYE.
-
What is the current stock price of Nova Eye Medical?
As of 19-Nov-2026 the stock price of Nova Eye Medical is $0.11.
-
What is the current market cap of Nova Eye Medical?
The current market capitalization of Nova Eye Medical is $30.6M.
-
Who are Nova Eye Medical’s competitors?
Wontech Co., Atricure, IRIDEX, DUKE Empirical, and Staar Surgical are some of the 8 competitors of Nova Eye Medical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process